top of page
daniel-price-mCGZPYjfROM-unsplash.jpg


Novapep is developing its biparetide peptide which is anti-inflammatory and cytoprotective to treat sepsis and other acute indications

Picture2.jpg

The Company

Novapep is a biotech company whose scientists invented the Biparetide agonist peptide structure, which mimics the cell-signalling mechanisms of Activated Protein C 


Sepsis Program

image.png

Based on highly promising preclinical data for biperatide in sepsis Novapep is developing intravenous biparetide for the treatment of sepsis which is anti-inflammatory, cytoprotective and provides endothelial barrier protection    

bottom of page